BRACHYTHERAPY, cilt.7, sa.1, ss.1-6, 2008 (SCI-Expanded)
PURPOSE: To report the acute and late treatment-related toxicities of combined permanent interstitial I-125 implantation delivered via real-time intraoperative planning and supplemental intensity-modulated radiotherapy (IMRT) for patients with clinically localized prostate cancer.